Published in Products

FDA approves Bausch+ Lomb’s TENEO excimer laser platform

This is editorially independent content
3 min read

Bausch + Lomb Corporation has received FDA approval for its TENEO Excimer Laser Platform, designed to be used in laser-assisted in situ keratomileusis (LASIK) surgery.

Updated Feb. 7, 2024:

George O. Waring IV, MD, FACS, internationally-renowned ophthalmologist and founder and medical director of the Waring Vision Institute, joined Glance President Jaclyn Garlich, OD, FAAO to provide his first impressions of the TENEO platform.

This isn’t the first refractive laser for B+L, right?

You’re correct! The company already offers the VICTUS Femtosecond Laser Platform that features a single, integrated workstation designed to deliver a wide range of laser cataract and corneal procedures.

Now about the TENEO … which patients does it treat?

Specifically, LASIK surgery in patients diagnosed with myopia and myopic astigmatism who:

  • Have up to -10.00 D MRSE (manifest refraction spherical equivalent), with sphere between -1.00 D and cylinder between 0.00 and -3.00 D
  • Are 22 years of age or older
  • Have had a stable refraction in the last 12 months, as clinically documented:
    • Spherical and cylindrical portions of the manifest distance refraction have not progressed at a rate of more than 0.50 D per year prior to the baseline examination in the eye(s) to be treated.

Gotcha. Now give me some details.

Marketed as the first excimer platform to be FDA approved in nearly 20 years—with over 50 countries already using it, according to B+L President of Global Surgical Luc Bonnefoy, the company is introducing TENEO (tuh-NAY-oh) (referred to as Technolas TENEO 317 Model 2 outside of the U.S.) as “the smallest excimer laser available in the United States.”

The laser features two record-setting components:

  • An advanced eye-tracker (operating at 1,740 Hz—currently the fastest of all flying spot excimer lasers in the U.S.)
  • High-speed (500 Hz) laser operating at an ablation time of an estimated 1.2 seconds per diopter—also currently the fastest of all similar lasers in the country.

Exactly how small is it?

The platform has a compact design of 6.8 sq ft, enabling clinicians to free up clinical space.

And is user-friendliness?

Per B+L, the platform includes a customizable graphical user interface (GUI) touch screen intended to provide surgeons with a simplified set up process and all-in-one access to patient data (without needing to refer to multiple screens).

Further, the laser’s 360° swiveling microscope adapts itself based on a surgeon’s height and posture.

How about for surgical planning?

Three steps are designed for a more streamlined, logical, and intuitive procedure:

  1. Selecting a patient
  2. Choosing and confirming treatment
  3. Treating

To note: The software algorithms on the platform leverage the manifest refraction without the need to use a nomogram.

Is patient comfort taken into consideration?

According to the company, the treatment bed has been designed to swing out for easy access and can also be customized for a patient’s head positioning.

Any potential risks or side effects associated with use?

See here for those details.

So… how can I get a hold of this for my practice?

Click here (and scroll to the bottom) to learn about how to acquire the TENEO Excimer Laser Platform.